Your browser doesn't support javascript.
loading
Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder.
Raleigh, M D; King, S J; Baruffaldi, F; Saykao, A; Hamid, F A; Winston, S; LeSage, M G; Pentel, P R; Pravetoni, M.
  • Raleigh MD; University of Minnesota Medical School, Department of Pharmacology, USA; Hennepin Healthcare Research Institute, USA. Electronic address: rale0011@umn.edu.
  • King SJ; Hennepin Healthcare Research Institute, USA.
  • Baruffaldi F; Hennepin Healthcare Research Institute, USA.
  • Saykao A; Hennepin Healthcare Research Institute, USA.
  • Hamid FA; University of Minnesota Medical School, Department of Pharmacology, USA.
  • Winston S; Winston Biopharmaceutical Consulting, USA.
  • LeSage MG; Hennepin Healthcare Research Institute, USA; University of Minnesota Medical School, Department of Medicine, USA.
  • Pentel PR; Hennepin Healthcare Research Institute, USA; University of Minnesota Medical School, Department of Medicine, USA.
  • Pravetoni M; University of Minnesota Medical School, Department of Pharmacology, USA; Hennepin Healthcare Research Institute, USA; University of Minnesota Medical School, Department of Medicine, USA; University of Minnesota Center for Immunology, USA.
Neuropharmacology ; 195: 108653, 2021 09 01.
Article en En | MEDLINE | ID: mdl-34126123
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxicodona / Encéfalo / Vacunas / Vacunación / Anticuerpos / Trastornos Relacionados con Opioides Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxicodona / Encéfalo / Vacunas / Vacunación / Anticuerpos / Trastornos Relacionados con Opioides Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article